Abstract:Vision impairment from corneal fibrosis is a common consequence of irregular corneal wound healing after injury. Intermediate-conductance calmodulin/calcium-activated K+ channels 3.1 (KCa3.1) play an important role in cell cycle progression and cellular proliferation. Proliferation and differentiation of corneal fibroblasts to myofibroblasts can lead to corneal fibrosis after injury. KCa3.1 has been shown in many non-ocular tissues to promote fibrosis, but its role in corneal fibrosis is still unknown. In this study, we characterized the expression KCa3.1 in the human cornea and its role in corneal wound healing in vivo using a KCa3.1 knockout (KCa3.1-/-) mouse model. Additionally, we tested the hypothesis that blockade of KCa3.1 by a selective KCa3.1 inhibitor, TRAM-34, could augment a novel interventional approach for controlling corneal fibrosis in our established in vitro model of corneal fibrosis. The expression of KCa3.1 gene and protein was analyzed in human and murine corneas. Primary human corneal fibroblast (HCF) cultures were used to examine the potential of TRAM-34 in treating corneal fibrosis by measuring levels of pro-fibrotic genes, proteins, and cellular migration using real-time quantitative qPCR, Western blotting, and scratch assay, respectively. Cytotoxicity of TRAM-34 was tested with trypan blue assay, and pro-fibrotic marker expression was tested in KCa3.1-/-. Expression of KCa3.1 mRNA and protein was detected in all three layers of the human cornea. The KCa3.1-/- mice demonstrated significantly reduced corneal fibrosis and expression of pro-fibrotic marker genes such as collagen I and α-smooth muscle actin (α-SMA), suggesting that KCa3.1 plays an important role corneal wound healing in vivo. Pharmacological treatment with TRAM-34 significantly attenuated corneal fibrosis in vitro, as demonstrated in HCFs by the inhibition TGFβ-mediated transcription of pro-fibrotic collagen I mRNA and α-SMA mRNA and protein expression (p<0.001). No evidence of cytotoxicity was observed. Our study suggests that KCa3.1 regulates corneal wound healing and that blockade of KCa3.1 by TRAM-34 offers a potential therapeutic strategy for developing therapies to cure corneal fibrosis in vivo.

Topical application of calcitonin gene-related peptide as a regenerative, antifibrotic, and immunomodulatory therapy for corneal injury

Sensory Nerves Promote Corneal Inflammation Resolution Via CGRP Mediated Transformation of Macrophages to the M2 Phenotype Through the PI3K/AKT Signaling Pathway

CGRP Released by Corneal Sensory Nerve Maintains Tear Secretion of the Lacrimal Gland

Sustained Release of Tacrolimus From a Topical Drug Delivery System Promotes Corneal Reinnervation

Progranulin Facilitates Corneal Repair Through Dual Mechanisms of Inflammation Suppression and Regeneration Promotion

Effect of Topical Recombinant Human Nerve Growth Factor on Corneal Epithelial Regeneration in Refractory Epithelial Keratopathy

Calcitonin Gene-Related Peptide Promotes the Wound Healing of Human Bronchial Epithelial Cells Via PKC and MAPK Pathways

Keratinocyte expression of calcitonin gene-related peptide β: Implications for neuropathic and inflammatory pain mechanisms

Collagen mimetic peptide repair of the corneal nerve bed in a mouse model of dry eye disease

Sustained Release of TPCA‐1 from Silk Fibroin Hydrogels Preserves Keratocyte Phenotype and Promotes Corneal Regeneration by Inhibiting Interleukin‐1 β Signaling

Calcitonin gene-related peptide alleviates hypertrophic scar formation by inhibiting the inflammation

TRPV1 + sensory nerves modulate corneal inflammation after epithelial abrasion via RAMP1 and SSTR5 signaling

Calcitonin gene-related peptide: a potential protective agent in cerebral ischemia-reperfusion injury

Topical calcitriol application promotes diabetic corneal wound healing and reinnervation through inhibiting NLRP3 inflammasome activation

Research Progress in Calcitonin Gene-Related Peptide and Bone Repair

Polymeric nanocapsules: a potential new therapy for corneal wound healing

CGRP sensory neurons promote tissue healing via neutrophils and macrophages

Activating transcription factor 3 (ATF3) and calcitonin gene-related peptide (CGRP) increase in trigeminal ganglion neurons in female rats after photorefractive keratectomy (PRK)-like corneal abrasion

KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis

Overexpression of CGRP receptor attenuates tendon graft degeneration in anterior cruciate ligament reconstruction

Calcitonin gene-related peptide regulates periodontal tissue regeneration